PATRICK GREGORY S 4
4 · SUPERNUS PHARMACEUTICALS, INC. · Filed Nov 6, 2020
Insider Transaction Report
Form 4
PATRICK GREGORY S
VP, Chief Financial Officer
Transactions
- Sale
Common Stock
2020-11-05$23.00/sh−5,000$115,000→ 44,463 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2020-11-05−5,000→ 15,000 totalExercise: $12.98Exp: 2026-03-01→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2020-11-05$12.98/sh+5,000$64,900→ 49,463 total
Footnotes (2)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2020.
- [F2]The option vests in four equal annual installments beginning on March 1, 2017.